Durable Mechanical Circulatory Support versus Organ Transplantation: Past, Present, and Future

Figure 7

HeartMate devices: the HeartMate II LVAD ((a)/(b)) is currently approved as a bridge to transplantation and as a destination therapy. The HeartMate III LVAD ((c)/(d)) is a new, third-generation centrifugal pump expected to undergo clinical trials in the near future. Images adopted from [51].

(a)

(b)

(c)

(d)